PALISADE BIO, INC. (PALI) AI Stock Price Forecast & Investment Analysis
Latest Analysis Date: July 18, 2025
PALISADE BIO, INC. (PALI) - Comprehensive Stock Analysis & Investment Research
Company Overview & Business Profile
PALISADE BIO, INC. (Stock Symbol: PALI)
is a leading company in the Life Sciences sector
, specifically operating within the Biological Products, (No Diagnostic Substances) industry.
The organization employs approximately 12 professionals worldwide
.
The company has established itself as
an emerging investment opportunity with substantial growth potential.
Financial Performance & Key Metrics Analysis
Market Capitalization: $4 million - Classified as a
small-cap investment offering high growth potential.
Return on Equity (ROE): -559.3% -
Below-average
shareholder return efficiency, indicating areas for operational improvement.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for PALISADE BIO, INC. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
PALISADE BIO, INC. strategically competes in the highly dynamic
Biological Products, (No Diagnostic Substances) marketplace,
representing an emerging small-cap investment with substantial growth potential and market disruption capabilities
.
.
PALISADE BIO, INC. Stock Price Chart and Technical Analysis
Loading chart data...
Loading PALISADE BIO, INC. interactive price chart and technical analysis...
Deep dive into PALISADE BIO, INC.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if PALISADE BIO, INC. stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For PALISADE BIO, INC.: With a P/E ratio of -0.15, the market sees the stock as potentially undervalued.
P/E Ratio-0.15x
P/B Ratio0.67x
Market Cap$4M
EPS$-10.47
Book Value/Share$1.21
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently PALISADE BIO, INC. converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For PALISADE BIO, INC.: An ROE of -559.3% indicates room for improvement in shareholder value creation.
ROE-559.3%
ROA-320.9%
ROIC-537.7%
Operating Margin-167287.9%
Net Margin-160816.4%
EBT Margin22.4%
Tax Rate6.3%
Understanding Financial Health Metrics
What these metrics mean: These ratios assess PALISADE BIO, INC.'s ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For PALISADE BIO, INC.: A current ratio of 4.43 indicates strong liquidity.
Current Ratio4.43x
Quick Ratio3.61x
D/E Ratio0.16x
Financial Leverage1.74x
Interest Coverage-37.9x
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal PALISADE BIO, INC.'s ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For PALISADE BIO, INC.: Free cash flow of $-17M indicates cash challenges that need attention.
Operating Cash Flow$-17M
Free Cash Flow$-17M
Capital Spending$-10030M
FCF/Sales8.8%
CapEx/Sales36.2%
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively PALISADE BIO, INC. uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For PALISADE BIO, INC.: An asset turnover of 0.49x suggests room for improvement in asset utilization.
Asset Turnover0.49x
Receivables Turnover6.6x
Inventory Turnover3.4x
Fixed Assets Turnover0.9x
Days Sales Outstanding55 days
Days Inventory107 days
Payables Period42 days
Cash Conversion Cycle120 days
Understanding Financial Statement Data
What these metrics mean: Key figures from PALISADE BIO, INC.'s income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
For PALISADE BIO, INC.:
Income Statement ($ Millions)
Operating Income$-14M
Net Income$-14M
R&D Expense$16M
SG&A Expense$3M
Balance Sheet Highlights ($ Millions)
Total Current Assets$99M
Cash & Short-term Investments$80M
Total Liabilities$43M
Short-term Debt$1M
Accounts Receivable$1M
Inventory$8M
Dividend & Shareholder Information
Shares Outstanding4M
Growth Metrics (YoY)
EPS Growth-1068.4%
PALISADE BIO, INC. (PALI) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for PALISADE BIO, INC. stock analysis.
Loading fundamental data...
Loading PALISADE BIO, INC. comprehensive fundamental analysis and insider trading data...
Latest PALISADE BIO, INC. Stock News & Market Analysis
Breaking news, analyst reports, and market updates affecting PALISADE BIO, INC. (PALI) stock price and investment outlook.
Carlsbad, CA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company advancing therapies for acute and chronic ...
Palisade Bio closed a $5 million public offering to fund clinical trials and research for autoimmune and inflammatory diseases. Quiver AI Summary Palisade Bio, Inc. has successfully closed an ...
Palisade Bio, Inc. Appoints Dr. Emil Chuang to Board of Directors to Enhance Clinical Strategy for Fibrostenotic Crohn's Disease and Ulcerative Colitis July 09, 2025 — 08:50 am EDT ...
Palisade Bio Inc.’s stock PALI more than doubled in price on Wednesday, after the company announced a licensing agreement with privately held Giiant Pharma Inc. Carlsbad, Calif.-based Palisade ...
– Live webcast with members of Palisade Bio management on Tuesday, April 16th at 12:00 PM ET Carlsbad, CA, April 11, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade ...
Upgrade Now Palisade Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference Palisade Bio, Inc. Wed, Feb 19, 2025, 9:00 AM4 min read In This Article: PALI ...
Carlsbad, CA, July 11, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company focused on developing and advancing novel ...
Stay up to date on how Palisade Bio Inc (PALI:XNAS) stock has performed compared to similar stocks in the same industry on a daily, quarterly, and monthly basis.
Palisade Bio Inc PALI Stock XNAS Rating as of Oct 8, 2024 Download PDF Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating Performance Dividends ...
– Lead program, GT-2108 for the treatment of moderate-to-severe ulcerative colitis advancing toward completion of I ND-enabling studies with IND filing expected by Q3 2024 – Inflammatory bowel ...
PALISADE BIO, INC. Competitors & Peer Analysis - Life Sciences Sector
Comparative analysis of PALISADE BIO, INC. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.
Frequently Asked Questions - PALISADE BIO, INC. Stock Forecast
How accurate are PALISADE BIO, INC. stock predictions?
Our AI model demonstrates 53% historical accuracy for PALI predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence PALISADE BIO, INC. stock price forecasts?
Based on our AI analysis, PALISADE BIO, INC. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are PALISADE BIO, INC. forecasts updated?
PALISADE BIO, INC. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced PALISADE BIO, INC. Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for PALISADE BIO, INC. stock.
